Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Science

• Publication date

  2006-10-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1126/SCIENCE.1134108PMID 17023659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurology®

  2007cited by this paper
• Infectious Prions in the Saliva and Blood of Deer with Chronic Wasting Disease

  2006cited by this paper
• Frontotemporal dementia: Clinicopathological correlations

  2006cited by this paper
• A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17.

  2006cited by this paper
• Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

  2006cited by this paper
• Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

  2006cited by this paper
• Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function.

  2005cited by this paper
• IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW，Thompson RW，et al//Proc Natl Acad Sci U S A

  2005cited by this paper
• Frontotemporal lobar degeneration: demographic characteristics of 353 patients.

  2005cited by this paper
• Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene

  2005cited by this paper
• Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation

  2005cited by this paper
• Ubiquitin Immunohistochemistry Suggests Classic Motor Neuron Disease, Motor Neuron Disease With Dementia, and Frontotemporal Dementia of the Motor Neuron Disease Type Represent a Clinicopathologic Spectrum

  2005cited by this paper
• Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs

  2004cited by this paper
• Structural diversity and functional implications of the eukaryotic TDP gene family.

  2004cited by this paper
• Clinicopathological correlates in frontotemporal dementia

  2004cited by this paper
• Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration

  2004cited by this paper
• Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance.

  2004cited by this paper
• Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis

  2003cited by this paper
• The overlap of amyotrophic lateral sclerosis and frontotemporal dementia

  2002cited by this paper
• Higher order arrangement of the eukaryotic nuclear bodies

  2002cited by this paper
• Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval

  2002cited by this paper
• Frontotemporal dementia: A review

  2002cited by this paper
• Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease.

  2001cited by this paper
• Nuclear factor TDP‐43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping

  2001cited by this paper
• Frontotemporal lobar degeneration

  1998cited by this paper
• Tau is a candidate gene for chromosome 17 frontotemporal dementia

  1998cited by this paper
• Hereditary dysphasic disinhibition dementia A frontotemporal dementia linked to 17 q21‐‐22

  1998cited by this paper
• Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

  1998cited by this paper
• Genomics

  1998cited by this paper
• Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs

  1995cited by this paper
• Brain

  1878cited by this paper

• Landscape of Protein Post-Translational Modifications in Age-Related Neurodegenerative Disorders: Implications in Protein Aggregation, Altered Cellular Processes, and Therapeutics.

  2026cites this paper
• Intrinsically disordered proteins and liquid-liquid phase separation in drug discovery.

  2026cites this paper
• Mutant TDP-43 drives impairments in axonal transport and glycolysis in a mouse stem-cell-derived motor neuron model of amyotrophic lateral sclerosis (ALS)

  2026cites this paper
• Are neurodegenerative diseases late-onset neurodevelopmental disorders? Tracing the developmental origins of neuronal vulnerability

  2026cites this paper
• From TDP-43/RNA complex formation to disease-linked TDP-43 aggregation through a structural and cellular approach

  2026cites this paper
• TDP-43 dysfunction leads to the accumulation of cryptic transposable element-derived exons, crypTEs, in iPSC derived neurons and ALS/FTD patient tissues

  2026cites this paper
• γ-Radiation induces region-specific subcellular alterations of amyotrophic lateral sclerosis and frontotemporal dementia markers in swine brain

  2026cites this paper
• Elucidation of Molecular Mechanisms of Lipid-Altered Cytotoxicity of TDP-43 Fibrils.

  2026cites this paper
• A neurotoxic cryptic peptide arising from TDP-43-dependent cryptic splicing of PKN1.

  2026cites this paper
• PML targets and resolves structured protein inclusions to mitigate neurodegeneration.

  2026cites this paper
• Direct observation and quantification of single nanocondensates of the low complexity domain of TDP-43.

  2026cites this paper
• ALS-related proteinopathies: From TDP-43 to mitochondrial proteinopathies.

  2026cites this paper
• Interactome screening implicates BAG6 as a suppressor of UBQLN2 misfolding in ALS/FTD

  2026cites this paper
• MicroRNAs and Long Non-Coding RNAs Affect the Mechanisms Involved in Age-Related Neurodegeneration in a Manner Depending on RNA-Binding Proteins

  2026cites this paper
• Potential role of stress granules and myogranules in amyotrophic lateral sclerosis

  2026cites this paper
• Glial Cells as Key Mediators in the Pathophysiology of Neurodegenerative Diseases

  2026cites this paper
• Advanced management options for patients with amyotrophic lateral sclerosis

  2026cites this paper
• Understanding liquid–liquid phase separation through TDP-43: fundamental principles, subcellular compartmentalisation, and role of solid inclusion formation

  2026cites this paper
• iPSC-Derived Microglia: Decoding Roles and Therapeutic Opportunities in Neurodegenerative Diseases.

  2026cites this paper
• The Mislocalization of TDP‐43 to Mitochondria Impairs Myotube Maturation

  2026cites this paper
• The Tale of the Guanosine Tract in Repeat Expansion Disorders

  2026cites this paper
• The Effect of Neurodegeneration on Ultrasonic Vocalisations (USV) and Their Neuronal Substrates in Mice and Rats: A Systematic Review

  2026cites this paper
• Refolding-assisted purification of native full-length TDP-43 compatible with BSL-2 safety regulations.

  2026cites this paper
• Exploratory assessment of phosphorylated TDP-43 immunoreactivity in minor salivary glands of patients with ALS.

  2026cites this paper
• Redox environment modulates aggregation of ataxin-3 in vitro - Implications for drug screening of cysteine-rich proteins.

  2026cites this paper
• From Evasion to Collapse: The Kinetic Cascade of TDP-43 and the Failure of Proteostasis

  2026cites this paper
• Inhibiting Glycogen Synthase Kinase 3 Suppresses TDP-43-Mediated Neurotoxicity in a Caspase-Dependent Manner

  2026cites this paper
• Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domains.

  2026cites this paper
• Calcineurin depletion coincides with phosphorylated TDP-43 deposition in a mouse model of ALS/FTLD-TDP

  2026cites this paper
• Superficial white matter microstructural impairments correlate with functional alterations and disease severity in early-stage amyotrophic lateral sclerosis.

  2026cites this paper
• TDP-43-mediated alternative polyadenylation is associated with a reduction in VPS35 and VPS29 expression in frontotemporal dementia

  2026cites this paper
• The utility of Gold Coast criteria for amyotrophic lateral sclerosis.

  2026cites this paper
• Distinct TAF15 amyloid filament folds define multiple subtypes of FTLD-TAF15

  2026cites this paper
• Regulation of gene expression by alternative polyadenylation in health and disease.

  2026cites this paper
• Analyses of the Effects of Wild‐Type TDP‐43 Overexpression in Oxytocin Neurons in Mice

  2026cites this paper
• Cytoplasmic TDP-43 leads to early behavioral impairments without neurodegeneration in a serotonergic neuron-specific C. elegans model

  2026cites this paper
• Pathological TDP-43 filaments accumulate at synapses and cause synaptic dysfunction

  2026cites this paper
• Concentration-dependent cytoplasmic phase separation of TDP-43 drives aggregation and proteinopathy.

  2026cites this paper
• Gene-targeted versus broad-spectrum therapies in ALS: comparative lessons and strategic outlook.

  2026cites this paper
• The Calcium Connection: Explaining Motor Neuron Vulnerability in ALS.

  2026cites this paper
• Small heat shock protein HSPB8 interacts with a pre-fibrillar TDP43 low complexity domain species to delay fibril formation.

  2026cites this paper
• Accurate conformational ensembles of intrinsically disordered proteins using reweighting based on NMR chemical shifts.

  2026cites this paper
• Neuronal TDP-43 regulates myelin formation via neurexin 1 mRNA stabilization.

  2026cites this paper
• Elevating Neuronal CYLD Causes Frontotemporal Dementia (FTD)-Relevant Behavioral and Physiological Deficits

  2026cites this paper
• Selective Silencing of TDP-43 P. G376D Mutation Reverses Key Amyotrophic Lateral Sclerosis-Related Cellular Deficits

  2026cites this paper
• Misfolded Proteins and Cognitive Decline: Mechanistic Insights into Neurodegenerative Disorders

  2026cites this paper
• Glioinflammation: disease-associated microglia and astrocytes in psychiatric disorders, neurodegeneration, and senescence.

  2026cites this paper
• Voxel‐Wise Whole‐Brain Analysis in Quantitative Susceptibility Mapping: A Narrative Review

  2026cites this paper
• Characterizing TDP‐43 involvement in vascular dementia

  2026cites this paper
• Intrathecal (G4C2)149 delivery in C9orf72-deficient mice yields mild motor dysfunction and ALS/FTD pathological hallmarks

  2026cites this paper
• FUS and TDP-43 aggregation are uncoupled from toxicity in ageing yeast models.

  2026cites this paper
• Axonal dying back of upper motor neurons in human ALS

  2026cites this paper
• Brain banking for research: can we achieve efficient banking?

  2026cites this paper
• Pleiotrophin/Midkine Pathway Is Dysregulated in a TDP‐43A315T Mouse Model of Amyotrophic Lateral Sclerosis (ALS)

  2026cites this paper
• Small molecule JRMS modulating importin-β1 chaperone activity as a therapeutic strategy reducing TDP-43 pathology.

  2026cites this paper
• Region-specific features of early glial activation and Aquaporin-4 dysregulation in conditional mouse models of TDP-43 proteinopathies

  2026cites this paper
• Midkine Attenuates Aβ Fibril Assembly and Amyloid Plaque Formation

  2025cites this paper
• Unraveling Molecular Targets for Neurodegenerative Diseases Through Caenorhabditis elegans Models

  2025cites this paper
• Nuclear translocation of the LINE-1 encoded ORF1 protein alters nuclear envelope integrity in human neurons.

  2025cites this paper
• TDP-43 seeding induces cytoplasmic aggregation heterogeneity and nuclear loss of function of TDP-43.

  2025cites this paper
• Seeded aggregation of TDP-43 induces its loss of function and reveals early pathological signatures.

  2025cites this paper
• Dysfunctional Mitochondria Characterize Amyotrophic Lateral Sclerosis Patients’ Cells Carrying the p.G376D TARDBP Pathogenetic Substitution

  2025cites this paper
• Alzheimer mimicry: LATE and PART

  2025cites this paper
• Decoding Stress Granules Dynamics: Implications for Neurodegenerative Disease.

  2025cites this paper
• The role of autophagy in the pathogenesis and treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)

  2025cites this paper
• scFv intrabody targeting wildtype TDP-43 presents protective effects in a cellular model of TDP-43 proteinopathy

  2025cites this paper
• Neurodegenerative diseases: Epigenetic regulatory mechanisms and therapeutic potential.

  2025cites this paper
• Bridging Mechanical Properties with Atomic Structures of Polymorphic α‐Synuclein Fibrils by Single‐Molecule Analysis and Molecular Dynamics Simulations

  2025cites this paper
• Biofilm-Associated Amyloid Proteins Linked with the Progression of Neurodegenerative Diseases

  2025cites this paper
• Targeted degradation of α-Synuclein using an evolved botulinum toxin protease

  2025cites this paper
• Cross-Interaction with Amyloid-β Drives Pathogenic Structural Transformation within the Amyloidogenic Core Region of TDP-43.

  2025cites this paper
• Recent advances in CDC7 kinase inhibitors: Novel strategies for the treatment of cancers and neurodegenerative diseases.

  2025cites this paper
• Alternative pre-mRNA Splicing and Gene Expression Patterns in Midbrain Lineage Cells Carrying Familial Parkinson’s Disease Mutations

  2025cites this paper
• ATXN2L primarily interacts with NUFIP2, the absence of ATXN2L results in NUFIP2 depletion, and the ATXN2-polyQ expansion triggers NUFIP2 accumulation

  2025cites this paper
• Artificial intelligence-augmented drug discovery identifies gefitinib as a potential treatment for ALS

  2025cites this paper
• Aggregates associated with amyotrophic lateral sclerosis sequester the actin-binding protein profilin 2.

  2025cites this paper
• ALS molecular subtypes are a combination of cellular and pathological features learned by deep multiomics classifiers

  2025cites this paper
• Hemispheric asymmetry in neurodegenerative diseases.

  2025cites this paper
• Relation of Alzheimer's disease-related TDP-43 proteinopathy to metrics from diffusion tensor imaging (DTI) and neurite orientation dispersion and density imaging (NODDI).

  2025cites this paper
• Zebrafish (Danio rerio) TDP43 negatively regulates PKZ-IRF3-mediated IFN I response.

  2025cites this paper
• Endogenous TDP-43 mislocalization in a novel knock-in mouse model reveals DNA repair impairment, inflammation, and neuronal senescence

  2025cites this paper
• Assessing Co‐Localization of ITM2B With Alzheimer's Disease and Limbic‐Predominant Age‐Related TDP‐43 Encephalopathy Neuropathologic Changes

  2025cites this paper
• No structure, no problem: Protein stabilization by Hero proteins and other chaperone-like IDPs.

  2025cites this paper
• Myopathic aggregation-prone variants in the TDP-43 prion-like domain: genetics paving the way.

  2025cites this paper
• Clinical and Imaging Features of Sporadic and Genetic Frontotemporal Lobar Degeneration TDP‐43 A and B

  2025cites this paper
• Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers

  2025cites this paper
• Familial ALS/FTD-associated RNA-Binding deficient TDP-43 mutants cause neuronal and synaptic transcript dysregulation in vitro

  2025cites this paper
• Drosophila WDFY3/Bchs overexpression impairs neural function

  2025cites this paper
• Role of tau versus TDP‐43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease

  2025cites this paper
• SUMO2/3 conjugation of TDP-43 protects against aggregation

  2025cites this paper
• The Regulation of TDP-43 Structure and Phase Transitions: A Review

  2025cites this paper
• The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration

  2025cites this paper
• Advancements in genetic research and RNA therapy strategies for amyotrophic lateral sclerosis (ALS): current progress and future prospects

  2025cites this paper
• pTDP-43 levels correlate with cell type–specific molecular alterations in the prefrontal cortex of C9orf72 ALS/FTD patients

  2025cites this paper
• A Twist in Yeast: New Perspectives for Studying TDP-43 Proteinopathies in S. cerevisiae

  2025cites this paper
• Structural insights and milestones in TDP-43 research: A comprehensive review of its pathological and therapeutic advances.

  2025cites this paper
• Drug repurposing in amyotrophic lateral sclerosis (ALS)

  2025cites this paper
• Acridine Benzimidazolium Derivatives Induced Protective Microglia Polarization and In Silico TDP-43 Interaction─Potential Implications for Amyotrophic Lateral Sclerosis.

  2025cites this paper
• Adaptor‐Mediated Trafficking of Tank Binding Kinase 1 During Diverse Cellular Processes

  2025cites this paper
• Organelle homeostasis requires ESCRTs.

  2025cites this paper